News

Cancer Research6d
Abstract 4329: Developing oncogenic mutant-selective antisense oligonucleotide to treat PIK3CA-mutated cancers
Search for other works by this author on: ...
Cancer Research6d
Abstract 410: The BTK degrader BGB-16673 shows anti-tumor activity in marginal zone lymphoma models
IOR - Institute of Oncology Research, Bellinzona, Switzerland.
Cancer Research4d
Former NCI Director to Lead Ohio Cancer Center
W. Kimryn Rathmell, MD, PhD, has accepted the role as CEO of The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. She was ...
Cancer Research6d
Abstract 7427: Use of large language models for clinical data abstraction from oncologic medical records
Search for other works by this author on: ...
Cancer Research6d
Abstract 1591: Mechanisms of BPM31510-induced cell death in cancer: lipid peroxidation and apoptosis pathways
Search for other works by this author on: ...
Cancer Research6d
Abstract 3503: ZW171, a differentiated 2+1 T cell-engaging bispecific antibody with antitumor activity in a range of mesothelin-expressing cancers
Zymeworks Inc., Vancouver, British Columbia, Canada.
Cancer Research6d
Abstract 1530: Elucidating the role of exogenous lipids in ferroptosis in castration resistant prostate cancer
Search for other works by this author on: ...
Cancer Research6d
Abstract 6331: Prevention of lung cancer growth by an edible mushroom-derived p-terphenyl antioxidant, Vialinin-A
Noorda College of Osteopathic Medicine, LLC, Provo, UT.
Cancer Research5d
No NIH Grants for Universities with DEI Programs, Israel Boycotts
The NIH will not award research grants to universities with diversity, equity, and inclusion (DEI) programs or boycotts of Israel, including those against Israeli companies or those that do business ...
Cancer Research6d
Depletion of effector regulatory T cells associates with major response to induction dual immune checkpoint blockade
Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...
Cancer Research6d
Abstract 5389: Adaptive OXPHOS and antioxidant defense in glucose-deprivation-resistant colon cancer cells
Ariel University, Ari'el, Israel.
Cancer Research6d
Abstract 4611: Microbiome-derived indole metabolites and response to immune checkpoint inhibitors in patients with hepatocellular carcinoma
Search for other works by this author on: ...